Market Tracker

10/24 6:05pm ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

109.91
Data as of Oct 24
 +1.82 / +1.68%
Today’s Change
58.06
Today|||52-Week Range
116.88
+47.93%
Year-to-Date

Today’s Trading

Previous close108.09
Today’s open108.12
Day’s range107.07 - 110.25
Volume939,320
Average volume (3 months)1,647,535
Market cap$25.7B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-296.00%
Earnings growth (this year)-44.45%
Earnings growth (next 5 years)+159.50%
Revenue growth (last year)-20.63%
P/E ratioNM
Price/Sales13.79
Price/Book18.63

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+1.24+0.81%
MYLMylan Inc+0.79+1.57%
ZTSZoetis Inc+0.47+1.30%
SHPGShire PLC+9.51+5.14%
Data as of 4:04pm ET, 10/24/2014

Financials

Next reporting dateOctober 27, 2014
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$1.2B
Annual profit (last year)-$445.0M
Net profit margin-36.72%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeff M. Leiden
Chief Financial Officer &
Executive Vice President
Ian F. Smith
Corporate headquarters
Cambridge, Massachusetts

Forecasts